Macular edema is swelling in the macula, the small central area of the retina responsible for sharp, detailed vision. The swelling happens when fluid leaks from blood vessels and collects in the retinal tissue, distorting its normal structure and reducing visual clarity. It’s one of the most common causes of central vision loss in adults, and it can develop as a complication of several different eye and systemic conditions.
How Fluid Builds Up in the Retina
The retina has a built-in defense system called the blood-retinal barrier, a set of tightly connected cell layers that control what passes between the bloodstream and retinal tissue. In macular edema, this barrier breaks down. Signaling proteins, particularly one called VEGF, loosen the seals between cells in the blood vessel walls. This allows proteins, salts, and other molecules to leak through gaps between cells or get shuttled directly across them in tiny transport bubbles.
Once these extra molecules accumulate in the retina, they pull water along with them through osmotic pressure. Fluid collects in pockets within the inner layers of the retina or beneath it, forming small cysts that disrupt the macula’s precisely layered architecture. That structural distortion is what causes the visual symptoms people notice.
Common Causes
Diabetes is the leading cause. When high blood sugar damages the small blood vessels in the retina (a condition called diabetic retinopathy), those vessels can leak fluid into the macula. This specific form, diabetic macular edema (DME), has been rising in prevalence. Among commercially insured adults with diabetes in the U.S., DME diagnoses increased from 0.7% in 2009 to 2.6% in 2018. Nationally representative data show that roughly 3.8% of U.S. adults over 40 with diabetes have DME.
Other common causes include:
- Retinal vein occlusion: when a vein in the retina becomes blocked, blood backs up and leaks into the macula.
- Uveitis: inflammation inside the eye from an overactive immune response, which can cause swelling anywhere in the eye including the macula.
- Wet age-related macular degeneration: abnormal new blood vessels grow beneath the retina and leak fluid or blood.
- Cataract surgery: a condition called Irvine-Gass syndrome, where the macula swells after an otherwise successful procedure. This affects roughly 0.1% to 2.4% of patients after uncomplicated surgery, with the highest incidence around five weeks after the operation.
- Certain medications: some glaucoma drugs can trigger macular swelling as a side effect.
- Retinitis pigmentosa: a genetic eye disease that can also involve macular swelling in some patients.
What It Feels Like
The hallmark symptom is blurred central vision, the kind that makes reading, recognizing faces, or seeing fine detail difficult. But macular edema can also cause more distinctive visual changes. Straight lines may appear wavy or bent, a distortion called metamorphopsia. Some people perceive objects as smaller than they actually are. Others notice a central blind spot, reduced color intensity, or a drop in contrast sensitivity that makes everything look slightly washed out.
Macular edema can sometimes produce no noticeable symptoms at all, especially in early stages or when only one eye is affected. That’s why people with diabetes, uveitis, or other risk conditions are typically monitored with regular eye exams even when their vision feels fine.
How It’s Diagnosed
The standard diagnostic tool is optical coherence tomography (OCT), a non-invasive scan that creates detailed cross-sectional images of the retina. It measures the thickness of the central macula in micrometers. For diabetic macular edema specifically, the diagnostic threshold is a central subfield thickness of 320 micrometers or more in men and 305 micrometers or more in women, based on criteria established by the Diabetic Retinopathy Clinical Research Network. These cutoffs represent roughly two standard deviations above normal thickness for people with diabetes who don’t have macular swelling.
Doctors also classify the edema by its exact location. “Center-involved” macular edema, meaning fluid is present within the central 1-millimeter circle of the fovea, generally requires more urgent treatment because it directly threatens the sharpest point of vision.
Treatment With Anti-VEGF Injections
The primary treatment for most forms of macular edema is a series of injections delivered directly into the eye. These contain medications that block VEGF, the protein responsible for making blood vessel walls leaky. The procedure sounds intimidating, but the eye is numbed beforehand, and each injection takes only seconds.
Treatment typically begins with a loading phase of monthly injections for at least the first two to three months. After that, the interval between injections is adjusted based on how the eye responds. If the swelling stays controlled, injections can be spaced out gradually, sometimes to as long as every 16 weeks. If fluid returns, the interval gets shortened back down, usually to a minimum of every four weeks.
Results from the landmark Protocol T trial give a sense of what to expect. Patients with diabetic macular edema who started treatment with average vision around 20/50 gained one to three lines on an eye chart after a year. Early response matters: eyes that gained 10 or more letters (about two lines) by 12 weeks went on to gain roughly 17 to 18 letters at two years, while eyes that gained fewer than 5 letters early on improved by only about 5 to 9 letters over the same period.
Steroid Implants as an Alternative
For patients who don’t respond well to anti-VEGF therapy, or who have macular edema driven by inflammation (as in uveitis), corticosteroid implants offer another option. These are tiny devices placed inside the eye that slowly release anti-inflammatory medication over time.
One type provides effective control of swelling for about three to four months before it wears off and may need to be replaced. A longer-acting option delivers a continuous low dose of steroid for approximately 30 to 36 months from a single implant. The tradeoff is that steroid implants carry a meaningful risk of raising eye pressure and accelerating cataract formation. Patients receiving them need regular monitoring, and some will need pressure-lowering drops or additional procedures to manage these side effects.
Monitoring Your Vision at Home
If you’ve been diagnosed with macular edema or are at risk for it, your eye doctor may give you an Amsler grid to use at home. It’s a simple square grid with a dot in the center, designed to detect subtle changes in your central vision between appointments.
To use it, hold the grid at your normal reading distance (about 12 to 15 inches) with your glasses or contacts on. Cover one eye and focus on the center dot without moving your gaze. While looking at the dot, check that all four corners are visible, every line appears perfectly straight, no areas look dark or blank, and no lines are blurred or faded. Then repeat with the other eye. Most specialists recommend doing this daily. If any lines look wavy, any sections appear missing, or anything else has changed since your last check, contact your eye care provider promptly. Catching a recurrence early makes a real difference in preserving vision.